372 related articles for article (PubMed ID: 31550856)
1. [Role of lncRNA Fez family zinc finger protein 1 antisense RNA1 in hepatocellular carcinoma].
Yao J; Wang XP; Zhang ZZ; Yang J; Yang Z; Qian HX
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):667-674. PubMed ID: 31550856
[No Abstract] [Full Text] [Related]
2. Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis.
Yao J; Yang Z; Yang J; Wang ZG; Zhang ZY
Aging (Albany NY); 2021 May; 13(10):13726-13738. PubMed ID: 34023817
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
[TBL] [Abstract][Full Text] [Related]
4. [Knockdown of Fez family zinc finger protein 1 antisense ribonucleic acid 1 (FEZF1-AS1) inhibits invasion and migration of esophageal squamous cell carcinoma cells by blocking JAK2/STAT3 pathway].
Cao Y; Wang X; Chen L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Apr; 36(4):317-324. PubMed ID: 32519669
[TBL] [Abstract][Full Text] [Related]
5. Expression of lncRNA MSC-AS1 in hepatocellular carcinoma cell lines and its effect on proliferation, apoptosis, and migration.
Kou X; Zhu J; Xie X; Hao M; Zhao Y
Turk J Gastroenterol; 2020 Dec; 31(12):860-867. PubMed ID: 33625998
[TBL] [Abstract][Full Text] [Related]
6. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA FEZF1-AS1 in human cancers.
Zhou Y; Xu S; Xia H; Gao Z; Huang R; Tang E; Jiang X
Clin Chim Acta; 2019 Oct; 497():20-26. PubMed ID: 31276636
[TBL] [Abstract][Full Text] [Related]
9. [LncRNA HULC promots HCC growth by downregulating miR-29].
Zhu LR; Feng JL; Liu XJ; Wang JM
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
[No Abstract] [Full Text] [Related]
10. Upregulation of LncRNA FAM83H-AS1 in hepatocellular carcinoma promotes cell proliferation, migration and invasion by Wnt/β-catenin pathway.
Ma YK; Shen TH; Yang XY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7855-7862. PubMed ID: 31599410
[TBL] [Abstract][Full Text] [Related]
11. LncRNA FEZF1-AS1 promotes colorectal cancer progression through regulating the miR-363-3p/PRRX1 pathway.
Zhang T; Yu S; Zhao S
Adv Clin Exp Med; 2021 Aug; 30(8):839-848. PubMed ID: 34286520
[TBL] [Abstract][Full Text] [Related]
12. [Effects of tumor protein translation control antisense RNA1 on radiosensitivity, proliferation, migration and invasion of hepatocellular carcinoma cells by targeting miR-30c-5p].
Zhai JJ; Du XR; Li CX
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1054-1061. PubMed ID: 34695895
[No Abstract] [Full Text] [Related]
13. LncRNA DCST1-AS1 accelerates the proliferation, metastasis and autophagy of hepatocellular carcinoma cell by AKT/mTOR signaling pathways.
Li J; Zhai DS; Huang Q; Chen HL; Zhang Z; Tan QF
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6091-6104. PubMed ID: 31364110
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma.
Chen N; Guo D; Xu Q; Yang M; Wang D; Peng M; Ding Y; Wang S; Zhou J
Oncotarget; 2016 Mar; 7(10):11271-83. PubMed ID: 26848625
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA (lncRNA) FOXD2-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Regulating MiR-185/AKT Axis.
Chen Z; Zhang Z; Zhao D; Feng W; Meng F; Han S; Lin B; Shi X
Med Sci Monit; 2019 Dec; 25():9618-9629. PubMed ID: 31841454
[TBL] [Abstract][Full Text] [Related]
17. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
He R; Zhang FH; Shen N
Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
[TBL] [Abstract][Full Text] [Related]
18. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
[TBL] [Abstract][Full Text] [Related]
19. Patrinia herba aqueous extract on the proliferation, apoptosis, invasion and migration of hepatocellular carcinoma cells.
Guan Z; Chen J; Li X
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):119-124. PubMed ID: 32538757
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]